183 related articles for article (PubMed ID: 3199841)
1. Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant disease.
Roberts MM; Juttner CA; To LB; Kimber RJ
Leuk Res; 1988; 12(10):817-21. PubMed ID: 3199841
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow fibre content in acute myeloid leukaemia before and after treatment.
Islam A; Catovsky D; Goldman JM; Galton DA
J Clin Pathol; 1984 Nov; 37(11):1259-63. PubMed ID: 6594351
[TBL] [Abstract][Full Text] [Related]
3. Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia.
Loeb DM; Bowers DC; Civin CI; Friedman AD
Med Pediatr Oncol; 2001 Oct; 37(4):365-71. PubMed ID: 11568900
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity].
Hiddemann W; Büchner T; Andreeff M; Arlin Z; Wörmann B; Clarkson BD
Onkologie; 1983 Aug; 6(4):179-83. PubMed ID: 6355946
[TBL] [Abstract][Full Text] [Related]
5. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.
Chang J; Morgenstern GR; Coutinho LH; Scarffe JH; Carr T; Deakin DP; Testa NG; Dexter TM
Bone Marrow Transplant; 1989 Jan; 4(1):5-9. PubMed ID: 2647188
[TBL] [Abstract][Full Text] [Related]
6. Etoposide in remission induction of adult acute myeloid leukemia.
Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of adult acute myeloid leukaemia.
Suri R; Kueh YK; Han P; Tan YO
Ann Acad Med Singap; 1990 Mar; 19(2):175-7. PubMed ID: 2346291
[TBL] [Abstract][Full Text] [Related]
8. Vincristine (NSC-67574), cytosine arabinoside (NSC-63878), 6 thioguanine (NSC-752) and daunorubicin (NSC-82151) (VAT-D): a pilot study of combination chemotherapy for remission induction in acute myeloid leukemia in adults.
Sartiano GP; Pfrimmer WJ; Turner AR
Med Pediatr Oncol; 1978; 4(3):205-12. PubMed ID: 277748
[TBL] [Abstract][Full Text] [Related]
9. Survival in 91 adults with acute myelogenous leukaemia treated with 1-6 intensive courses of chemotherapy.
Evensen SA; Brinch L; Stavem P; Tjønnfjord G
J Intern Med; 1992 Nov; 232(5):433-7. PubMed ID: 1453128
[TBL] [Abstract][Full Text] [Related]
10. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
Rees JK; Gray RG; Swirsky D; Hayhoe FG
Lancet; 1986 Nov; 2(8518):1236-41. PubMed ID: 2878130
[TBL] [Abstract][Full Text] [Related]
11. A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
Eur J Cancer (1965); 1974 Jul; 10(7):413-8. PubMed ID: 4532961
[No Abstract] [Full Text] [Related]
12. Day 4 bone marrow aspirate for prediction of resistance to induction chemotherapy in acute myeloid leukemia.
Archimbaud E; Treille-Ritouet D; Guyotat D; Viala JJ; Fiere D
Leuk Res; 1987; 11(3):281-3. PubMed ID: 3470576
[TBL] [Abstract][Full Text] [Related]
13. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
14. A randomized comparison of post-consolidation therapy in acute non-lymphoid leukaemia: a study of the Italian cooperative group GIMEMA.
Petti MC; Mandelli F; Vegna ML; Broccia G; Carotenuto M; De Rosa F; Di Marco P; Di Raimondo F; Fioritoni G; Leone G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():119-20. PubMed ID: 2653486
[No Abstract] [Full Text] [Related]
15. Retrospective analysis of 158 cases of adult acute leukaemia: factors influencing prognosis and treatment response.
Januszewicz E; Firkin FC; Chesterman CN; Garson OM; Beswick W; Keating MJ; Penington DG
Aust N Z J Med; 1982 Jun; 12(3):238-45. PubMed ID: 6956290
[TBL] [Abstract][Full Text] [Related]
16. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
[No Abstract] [Full Text] [Related]
19. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
[TBL] [Abstract][Full Text] [Related]
20. Clonality switch in acute myeloid leukemia.
Yin JA; Jowitt SN
Leuk Lymphoma; 1996 Jun; 22(1-2):125-30. PubMed ID: 8724539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
